ZNF347
gene geneOn this page
Also known as ZNF1111
Summary
ZNF347 (zinc finger protein 347, HGNC:16447) is a protein-coding gene on chromosome 19q13.42, encoding Zinc finger protein 347 (Q96SE7). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 84671 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 141 total
- MANE Select transcript:
NM_032584
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16447 |
| Approved symbol | ZNF347 |
| Name | zinc finger protein 347 |
| Location | 19q13.42 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ZNF1111 |
| Ensembl gene | ENSG00000197937 |
| Ensembl biotype | protein_coding |
| Entrez | 84671 |
Gene structure
Transcript identifiers
Ensembl transcripts: 18 — 17 protein_coding, 1 retained_intron
ENST00000334197, ENST00000452676, ENST00000595710, ENST00000595967, ENST00000597183, ENST00000599096, ENST00000601469, ENST00000601804, ENST00000882585, ENST00000882586, ENST00000882587, ENST00000882588, ENST00000882589, ENST00000882590, ENST00000914572, ENST00000914574, ENST00000948849, ENST00000948850
RefSeq mRNA: 3 — MANE Select: NM_032584
NM_001172674, NM_001172675, NM_032584
CCDS: CCDS33097, CCDS54314
Canonical transcript exons
ENST00000334197 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001298405 | 53148681 | 53148809 |
| ENSE00002451437 | 53149241 | 53149367 |
| ENSE00003135539 | 53134935 | 53142556 |
| ENSE00003157594 | 53159009 | 53159053 |
| ENSE00003507234 | 53153733 | 53153793 |
Expression profiles
Bgee: expression breadth ubiquitous, 181 present calls, max score 86.38.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.1152 / max 78.0778, expressed in 988 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 182554 | 2.1152 | 988 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adrenal tissue | UBERON:0018303 | 86.38 | gold quality |
| calcaneal tendon | UBERON:0003701 | 85.35 | gold quality |
| colonic epithelium | UBERON:0000397 | 84.72 | gold quality |
| sural nerve | UBERON:0015488 | 84.07 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.93 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.08 | gold quality |
| buccal mucosa cell | CL:0002336 | 79.84 | gold quality |
| tendon | UBERON:0000043 | 78.50 | gold quality |
| ganglionic eminence | UBERON:0004023 | 77.97 | gold quality |
| islet of Langerhans | UBERON:0000006 | 77.23 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.20 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 77.04 | gold quality |
| cortical plate | UBERON:0005343 | 77.02 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.93 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.88 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 76.79 | gold quality |
| body of uterus | UBERON:0009853 | 75.74 | gold quality |
| ventricular zone | UBERON:0003053 | 75.56 | gold quality |
| cerebellum | UBERON:0002037 | 75.26 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 75.16 | gold quality |
| right ovary | UBERON:0002118 | 74.94 | gold quality |
| right adrenal gland | UBERON:0001233 | 74.90 | gold quality |
| adrenal gland | UBERON:0002369 | 74.83 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 74.70 | gold quality |
| left adrenal gland | UBERON:0001234 | 74.68 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 74.67 | gold quality |
| left ovary | UBERON:0002119 | 74.61 | gold quality |
| endocervix | UBERON:0000458 | 74.36 | gold quality |
| pancreas | UBERON:0001264 | 74.23 | gold quality |
| spleen | UBERON:0002106 | 74.02 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.59 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2688.1 | ZNF347 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605320
miRNA regulators (miRDB)
86 targeting ZNF347, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-4658 | 99.77 | 64.94 | 514 |
| HSA-MIR-6790-5P | 99.77 | 65.24 | 505 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
| HSA-MIR-6505-5P | 99.73 | 69.25 | 1595 |
Cross-species orthologs
30 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf646 | ENSDARG00000061424 |
| danio_rerio | si:dkey-154p10.3 | ENSDARG00000068366 |
| danio_rerio | si:dkey-89b17.4 | ENSDARG00000075545 |
| danio_rerio | zgc:66472 | ENSDARG00000075916 |
| danio_rerio | si:ch211-148l7.4 | ENSDARG00000094469 |
| danio_rerio | znf576.1 | ENSDARG00000097819 |
| drosophila_melanogaster | Sry-delta | FBGN0003512 |
| drosophila_melanogaster | az2 | FBGN0025185 |
| drosophila_melanogaster | hang | FBGN0026575 |
| drosophila_melanogaster | CG3032 | FBGN0029928 |
| drosophila_melanogaster | CG2129 | FBGN0030008 |
| drosophila_melanogaster | CG11695 | FBGN0030316 |
| drosophila_melanogaster | CG8944 | FBGN0030680 |
| drosophila_melanogaster | CG7101 | FBGN0030963 |
| drosophila_melanogaster | CG1602 | FBGN0033186 |
| drosophila_melanogaster | CG18011 | FBGN0033491 |
| drosophila_melanogaster | CG12942 | FBGN0033569 |
| drosophila_melanogaster | CG8089 | FBGN0033993 |
| drosophila_melanogaster | indra | FBGN0035213 |
| drosophila_melanogaster | CG10654 | FBGN0036294 |
| drosophila_melanogaster | CG6791 | FBGN0037918 |
| drosophila_melanogaster | CG17803 | FBGN0038547 |
| drosophila_melanogaster | CG12219 | FBGN0043796 |
| drosophila_melanogaster | CG30020 | FBGN0050020 |
| drosophila_melanogaster | pzg | FBGN0259785 |
| drosophila_melanogaster | mld | FBGN0263490 |
| drosophila_melanogaster | zf30C | FBGN0270924 |
| caenorhabditis_elegans | ztf-15 | WBGENE00011066 |
| caenorhabditis_elegans | WBGENE00013734 | |
| caenorhabditis_elegans | WBGENE00015649 |
Paralogs (36): ZNF302 (ENSG00000089335), ZNF184 (ENSG00000096654), CTCF (ENSG00000102974), ZNF574 (ENSG00000105732), ZBTB24 (ENSG00000112365), ZNF142 (ENSG00000115568), CTCFL (ENSG00000124092), ZNF473 (ENSG00000142528), ZNF827 (ENSG00000151612), ZNF689 (ENSG00000156853), ZNF208 (ENSG00000160321), ZNF91 (ENSG00000167232), ZNF526 (ENSG00000167625), ZNF764 (ENSG00000169951), ZNF747 (ENSG00000169955), ZNF282 (ENSG00000170265), ZNF160 (ENSG00000170949), ZNF497 (ENSG00000174586), ZBTB34 (ENSG00000177125), ZNF771 (ENSG00000179965), ZNF48 (ENSG00000180035), ZNF594 (ENSG00000180626), ZBTB37 (ENSG00000185278), ZFP92 (ENSG00000189420), ZNF107 (ENSG00000196247), ZNF729 (ENSG00000196350), ZNF569 (ENSG00000196437), ZNF420 (ENSG00000197050), ZNF785 (ENSG00000197162), ZNF665 (ENSG00000197497), ZNF181 (ENSG00000197841), ZNF84 (ENSG00000198040), ZBTB48 (ENSG00000204859), ZNF845 (ENSG00000213799), ZNF99 (ENSG00000213973), ZNF688 (ENSG00000229809)
Protein
Protein identifiers
Zinc finger protein 347 — Q96SE7 (reviewed: Q96SE7)
Alternative names: Zinc finger protein 1111
All UniProt accessions (5): Q96SE7, M0QXR8, M0QZE2, M0QZJ6, M0R1E9
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96SE7-1 | 1 | yes |
| Q96SE7-2 | 2 |
RefSeq proteins (3): NP_001166145, NP_001166146, NP_115973* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (89 total): strand 26, helix 21, zinc finger region 20, turn 13, cross-link 2, sequence variant 2, sequence conflict 2, chain 1, domain 1, splice variant 1
Structure
Experimental structures (PDB)
16 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2EMA | SOLUTION NMR | |
| 2EMP | SOLUTION NMR | |
| 2EN4 | SOLUTION NMR | |
| 2ENE | SOLUTION NMR | |
| 2ENF | SOLUTION NMR | |
| 2EOE | SOLUTION NMR | |
| 2EOW | SOLUTION NMR | |
| 2EQ0 | SOLUTION NMR | |
| 2EQ1 | SOLUTION NMR | |
| 2EQ2 | SOLUTION NMR | |
| 2EQ3 | SOLUTION NMR | |
| 2YTI | SOLUTION NMR | |
| 2YTK | SOLUTION NMR | |
| 2YTN | SOLUTION NMR | |
| 2YTR | SOLUTION NMR | |
| 2YU8 | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96SE7-F1 | 67.87 | 0.05 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 253, 827
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 48 (showing top):
MODULE_128, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, MODULE_170, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR579_3P, MIR664B_3P, MIR222_5P, MIR10393_5P, MIR150_3P, MIR6728_3P, MIR6773_3P, MIR1912_5P, GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP, MIR4686, MIR3137
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
428 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF347 | SPINT1 | O43278 | 503 |
| ZNF347 | CIROZ | Q8N9H9 | 396 |
| ZNF347 | DNAJA1 | P31689 | 323 |
| ZNF347 | WDR70 | Q9NW82 | 317 |
| ZNF347 | NWD2 | Q9ULI1 | 305 |
| ZNF347 | RCCD1 | A6NED2 | 303 |
| ZNF347 | PNMA1 | Q8ND90 | 299 |
| ZNF347 | ZNF704 | Q6ZNC4 | 297 |
| ZNF347 | MRPL36 | Q9P0J6 | 293 |
| ZNF347 | TBC1D23 | Q9NUY8 | 289 |
| ZNF347 | U2SURP | O15042 | 272 |
| ZNF347 | TULP4 | Q9NRJ4 | 265 |
| ZNF347 | PITPNB | P48739 | 258 |
| ZNF347 | PPP1R2 | P41236 | 256 |
| ZNF347 | PALMD | Q9NP74 | 253 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF347 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (1): ZNF347 (Affinity Capture-RNA)
ESM2 similar proteins: A0A087WUL8, A0A0J9YWL9, A0A0J9YY54, A0A0U1RQI7, A6NJ88, A6QL64, B4DH59, D3ZVV1, E9Q6E9, F1LWT0, O04492, O88799, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P18583, P53353, Q08AG5, Q0P6D6, Q2EG98, Q3BBV2, Q4ZJZ1, Q5HY64, Q5JPF3, Q5QGU6, Q5TAG4, Q5TI25, Q5XHX6, Q6P3W6, Q6P902, Q6XPR3, Q6ZQX7, Q86T75, Q86VE3, Q86VQ3, Q8N2N9, Q8N660, Q8N693, Q96EQ9
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
141 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 128 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1491 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:53132855:CG:C | donor_gain | 0.9900 |
| 19:53153795:T:C | acceptor_gain | 0.9900 |
| 19:53132854:A:AC | donor_gain | 0.9800 |
| 19:53132855:C:CC | donor_gain | 0.9800 |
| 19:53149280:C:A | donor_gain | 0.9800 |
| 19:53148814:T:C | acceptor_gain | 0.9700 |
| 19:53132698:TCA:T | donor_gain | 0.9600 |
| 19:53148771:C:G | acceptor_gain | 0.9600 |
| 19:53148816:A:C | acceptor_gain | 0.9600 |
| 19:53132855:CGCT:C | donor_gain | 0.9500 |
| 19:53143420:T:TA | donor_gain | 0.9500 |
| 19:53148788:C:CC | acceptor_gain | 0.9500 |
| 19:53153795:T:TC | acceptor_gain | 0.9500 |
| 19:53158531:TCA:T | donor_gain | 0.9500 |
| 19:53159007:A:AC | donor_gain | 0.9500 |
| 19:53159008:C:CC | donor_gain | 0.9500 |
| 19:53159008:CG:C | donor_gain | 0.9500 |
| 19:53142431:C:A | donor_gain | 0.9400 |
| 19:53153727:CCTTA:C | donor_loss | 0.9400 |
| 19:53153728:CTTA:C | donor_loss | 0.9400 |
| 19:53153729:TTA:T | donor_loss | 0.9400 |
| 19:53153730:TACCT:T | donor_loss | 0.9400 |
| 19:53153732:C:A | donor_loss | 0.9400 |
| 19:53142557:C:CC | acceptor_gain | 0.9300 |
| 19:53149215:G:T | donor_gain | 0.9300 |
| 19:53158815:TGA:T | donor_gain | 0.9200 |
| 19:53158993:A:AC | donor_gain | 0.9200 |
| 19:53158994:C:CC | donor_gain | 0.9200 |
| 19:53149211:T:TA | donor_gain | 0.9100 |
| 19:53149234:T:TA | donor_gain | 0.9100 |
AlphaMissense
5559 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:53141346:A:C | F494L | 0.996 |
| 19:53141346:A:T | F494L | 0.996 |
| 19:53141348:A:G | F494L | 0.996 |
| 19:53141514:A:C | F438L | 0.996 |
| 19:53141514:A:T | F438L | 0.996 |
| 19:53141516:A:G | F438L | 0.996 |
| 19:53140674:A:C | F718L | 0.995 |
| 19:53140674:A:T | F718L | 0.995 |
| 19:53140676:A:G | F718L | 0.995 |
| 19:53141094:G:C | F578L | 0.995 |
| 19:53141094:G:T | F578L | 0.995 |
| 19:53141096:A:G | F578L | 0.995 |
| 19:53141598:G:C | F410L | 0.995 |
| 19:53141598:G:T | F410L | 0.995 |
| 19:53141600:A:G | F410L | 0.995 |
| 19:53140758:A:C | F690L | 0.994 |
| 19:53140758:A:T | F690L | 0.994 |
| 19:53140760:A:G | F690L | 0.994 |
| 19:53141682:A:C | F382L | 0.994 |
| 19:53141682:A:T | F382L | 0.994 |
| 19:53141684:A:G | F382L | 0.994 |
| 19:53141430:A:C | F466L | 0.993 |
| 19:53141430:A:T | F466L | 0.993 |
| 19:53141432:A:G | F466L | 0.993 |
| 19:53141766:G:C | F354L | 0.993 |
| 19:53141766:G:T | F354L | 0.993 |
| 19:53141768:A:G | F354L | 0.993 |
| 19:53141178:G:C | F550L | 0.992 |
| 19:53141178:G:T | F550L | 0.992 |
| 19:53141180:A:G | F550L | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000179911 (19:53146830 A>C), RS1000197385 (19:53159141 G>A,C), RS1000370832 (19:53140732 T>C), RS1000440290 (19:53154593 G>A), RS1000544979 (19:53156406 G>A,C,T), RS1000650468 (19:53155499 ATTT>A,AT,ATTTT), RS1000690474 (19:53142547 G>T), RS1000800298 (19:53148412 G>A), RS1000820717 (19:53136714 T>C), RS1000832034 (19:53136396 T>C), RS1000935066 (19:53160788 A>C), RS1000940639 (19:53144365 G>A), RS1001145442 (19:53142199 A>C), RS1001174491 (19:53158270 G>A), RS1001269209 (19:53158109 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression | 2 |
| Air Pollutants | decreases expression, increases abundance | 2 |
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| pirinixic acid | decreases expression, increases activity, affects binding | 1 |
| bisphenol A | affects cotreatment, decreases methylation | 1 |
| potassium chromate(VI) | increases expression | 1 |
| avobenzone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Cisplatin | increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Vanadates | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.